These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9587076)

  • 1. Outstanding issues in radiation dose-fractionation studies.
    Hendry JH; Mackay RI; Roberts SA; Slevin NJ
    Int J Radiat Biol; 1998 Apr; 73(4):383-94. PubMed ID: 9587076
    [No Abstract]   [Full Text] [Related]  

  • 2. Individualizing cancer treatment: biological optimization models in treatment planning and delivery.
    Brahme A
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):327-37. PubMed ID: 11173125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
    Bentzen SM; Saunders MI; Dische S; Bond SJ
    Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical examinations on the different fractionation rhythms for radiation therapy. Dynamic fractionation and behavior of heterogeneous tumor cell population (clinical and technical aspects)].
    Siracká E; Durkovský J; Jancina J
    Radiobiol Radiother (Berl); 1975; 16(4):443-9. PubMed ID: 1208828
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dose fractionation in distance radiotherapy of malignant neoplasms].
    Kozlov AP; Akimov AA
    Vopr Onkol; 1983; 29(11):105-16. PubMed ID: 6359680
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiotherapy of tumours by a dynamic dose-fractionation regime combined with oxygen inhalation (preliminary report of 20 cases of tumours localized to the head and neck and uterine cervix).
    Siracká E; Durkovský J; Jancina J; Révész L
    Neoplasma; 1971; 18(6):607-16. PubMed ID: 5160901
    [No Abstract]   [Full Text] [Related]  

  • 7. Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial.
    Bartelink H; Van den Bogaert W; Horiot JC; Jager J; van Glabbeke M
    Eur J Cancer; 2002 Mar; 38(5):667-73. PubMed ID: 11916549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New trends in radiotherapy for head and neck cancer.
    Bourhis J; Etessami A; Lusinchi A
    Ann Oncol; 2005; 16 Suppl 2():ii255-7. PubMed ID: 15958468
    [No Abstract]   [Full Text] [Related]  

  • 9. Absence of cervical radiation myelitis after hyperfractionated radiation therapy with and without concurrent chemotherapy for locally advanced, unresectable, nonmetastatic squamous cell carcinoma of the head and neck.
    Jeremic B; Shibamoto Y; Igrutinovic I
    J Cancer Res Clin Oncol; 2001 Nov; 127(11):687-91. PubMed ID: 11710599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In response to Drs. Dubben, Beck-Bornholdt, and Llogie.
    Ang KK; Berkey BA; Pajak TF; Fu KK
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1148-50. PubMed ID: 11958923
    [No Abstract]   [Full Text] [Related]  

  • 11. Observations on radiation response of tumour and healthy tissue in cancer patients given a dynamic dose-fractionation under oxygen breathing.
    Siracká E; Durkovský J; Jancina J; Revesz L
    Strahlentherapie; 1972 Nov; 144(5):584-90. PubMed ID: 4646684
    [No Abstract]   [Full Text] [Related]  

  • 12. Dynamic dose-fractionation combined with oxygen breathing at ambient pressure and high-dose metronidazole in head and neck, and uterine cervix cancer.
    Siracká E; Kubovcáková N; Durkovský J; Jancina J; Boljesíková E
    Neoplasma; 1983; 30(6):725-31. PubMed ID: 6656969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radiation biology of normal tissues. Scientific progress and perspectives].
    Dörr W; Herskind C
    Strahlenther Onkol; 2012 Nov; 188 Suppl 3():295-8. PubMed ID: 22907577
    [No Abstract]   [Full Text] [Related]  

  • 14. Immediate results of weekly fractionation in external radiotherapy.
    Dvivedi M; Pradhan DG
    Int J Radiat Oncol Biol Phys; 1978; 4(7-8):573-8. PubMed ID: 101487
    [No Abstract]   [Full Text] [Related]  

  • 15. 21 years of biologically effective dose.
    Fowler JF
    Br J Radiol; 2010 Jul; 83(991):554-68. PubMed ID: 20603408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing the dose rate and technique in cervical carcinoma--balancing cases versus complications.
    Petereit DG; Fowler JF; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1195-7. PubMed ID: 8083092
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered fractionation in radiotherapy for head and neck cancer: too early to close the race and announce the winner?
    Bentzen SM; Dische S
    Radiother Oncol; 1999 May; 51(2):105-7. PubMed ID: 10435799
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers.
    Dobrowsky W; Naudé J
    Radiother Oncol; 2000 Nov; 57(2):119-24. PubMed ID: 11054514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous chemoradiation: accelerated hypofractionation.
    Alastuey I; Montagut J
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1201. PubMed ID: 7993448
    [No Abstract]   [Full Text] [Related]  

  • 20. Comment on 'viability of the EUD and TCP concepts as reliable dose indicators'.
    Vaarkamp J; Zhu Y
    Phys Med Biol; 2000 Jul; 45(7):L11-6. PubMed ID: 10943940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.